Loading…
Hill Creek Cultural Preservation and Energy Development Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
91pct
156d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2014 · fourth_quarter · Environment/Superfund
Bills with similar content found using semantic analysis.
Sources: Congress.gov
U.S. National Strategy on Combatting Wildlife Trafficking - support Senate and House Wildlife Trafficking Legislation (no bill number) - support Multinational Species Conservation Funds Reauthorization Act of 2013 (H.R. 39) - support Great Ape Conservation Reauthorization Amendments Act of 2013 (H.R. 1328) - support Marine Turtle Conservation Reauthorization Act of 2013 (H.R. 1329) - support Multinational Species Conservation Funds Semipostal Stamp Reauthorization Act of 2013 (H.R. 262 / S. 231) - support Big Cats and Public Safety Protection Act (H.R. 1998 / S. 1381) - support Senator Paul Simon Water for the World Act (H.R. 2901) - support legislation and advocated inclusion of integrating water resources management and ecosystems in water, sanitation, and hygiene program and project planning and implementation Targeted Use of Sanctions for Killing Elephants in Their Range Act of 2014 (H.R. 5454) - support Lawful Ivory Protection Act of 2014 (H.R. 5052 / S. 2587) - oppose National Defense Authorization Act for Fiscal Year 2015 (H.R. 4335 / S. 2410) - support amendment regarding wildlife trafficking and transnational organized crime Wildlife Trafficking Enforcement Act of 2015 (S. 27) - support foreign policy on wildlife trafficking and legislation on ivory and rhino horn trade Pirate Fishing Elimination Act (S. 267) - support Agriculture Act of 2014 - support implementation of Sodsaver and Conservation Compliance-Crop Insurance Subsidies Designation of Bison as National Mammal - support International and Transboundary Freshwater - support cooperation with Mexico regarding Rio Grande; support strong position regarding conservation of the Mekong River U.S. Government Engagement with Myanmar - support direct U.S. Government investments in programs to protect Myanmars environment Illegal, Unreported and Unregulated Seafood - support rulemaking to ensure all seafood sold in the U.S. is traceable to legal sources; support establishment of new rules to require proof of legality for market access Climate Green Fund - support strong U.S. Government climate pollution target and financial contribution to fund U.N. Climate Negotiations - support strong U.S. negotiation positions in negotiations; support strong target for international emission reduction commitment Establishment of Tribal National Park as Part of Badlands National Park - support bison restoration that would happen under the General Management Plan agreed to by U.S. Government and Oglala-Souix Tribe
Client expense: $100,000 · Firm income: Not reported
Government targets: Bureau of Indian Affairs (BIA), Central Intelligence Agency (CIA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), Natl Park Service (NPS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Fish & Wildlife Service (USFWS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Health Issues
S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. No. 111-148, Patient Protection and Affordable Care; prescription drug user fee reauthorization issues; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality in Drug Compounding Act of 2013
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
S.27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act
Client expense: Not reported · Firm income: Not reported
2014 · second_quarter · Pharmacy
S.27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act
Client expense: Not reported · Firm income: Not reported
2014 · second_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Client expense: Not reported · Firm income: $180,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Indian/Native American Affairs
Exchange of Land between Tribe and State of Utah (H.R. 356, S. 27), Economic Development and General Legislative Affairs - including Indian Health, Labor (H.R. 1226), and Energy; Energy Legislation (H.R. 1548, H.R. 2728 and H.R. 1965) and Related Proposed Regulations; Energy Tax-Related matters/legislation.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2013 · fourth_quarter · Indian/Native American Affairs
Exchange of Land between Tribe and State of Utah (H.R. 356, S. 27), Economic Development and General Legislative Affairs - including Indian Health, Labor (H.R. 1226), and Energy; Energy Legislation (H.R. 1548, H.R. 2728 and H.R. 1965) and Related Proposed Regulations; Energy Tax-Related matters/legislation.
Client expense: Not reported · Firm income: $20,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, White House Office
2013 · fourth_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Client expense: Not reported · Firm income: $180,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Science/Technology
In support of NSF funding for political science research. In support of funding for NSF, NIST, NASA Space Grant, and NASA MIDEX program. In support of legislative solutions for stewardship of Federal Helium Reserve and H.R. S27, the Helium Stewardship Act. In support of funding for the Large Synoptic Survey Telescope. In support of reauthorization of the America COMPETES Act.
Client expense: $105,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2013 · third_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Client expense: Not reported · Firm income: $180,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Discussions regarding health care reform, cost containment, generic drugs, and Medicare Part D, Pay for Delay S. 27, Preserve Access to Affordable Generics Act; S. 1882, Fair And Immediate Release of Generic Drugs Act H.R. 1063, The Smart Act: Employer Health Care Spending;
Client expense: $1,970,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2013 · second_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Client expense: Not reported · Firm income: $180,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Health Issues
Discussions regarding health care reform, cost containment, generic drugs, and Medicare Part D, Pay for Delay S. 27, Preserve Access to Affordable Generics Act; S. 1882, Fair And Immediate Release of Generic Drugs Act H.R. 1063, The Smart Act: Employer Health Care Spending;
Client expense: $1,840,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2013 · first_quarter · Health Issues
S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Prescription Drug User Fee Reauthorization issues.
Client expense: Not reported · Firm income: $180,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE